Deutsche Bank’s Rosetta Genomics ROSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$0 Hold
2
– – ﹤0.01% 5351
2017
Q3
$0 Buy
+2
New – ﹤0.01% 5332
2017
Q1
– Hold
0
– – – 5286
2016
Q4
– Hold
0
– – – 5224
2016
Q3
– Hold
0
– – – 5441
2016
Q2
– Hold
0
– – – 5494

Other funds holding ROSG

Deutsche Bank's ROSG Position: Q4 2017 in Review

Deutsche Bank held its Rosetta Genomics (ROSG) position steady in Q4 2017 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5351.

Deutsche Bank first reported a position in ROSG in Q3 2017 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold ROSG as of Q4 2017.

  • Deutsche Bank held 2 shares of Rosetta Genomics worth $0 as of Q4 2017.
  • Deutsche Bank left its Rosetta Genomics share count unchanged in Q4 2017.
  • Rosetta Genomics made up ﹤0.01% of Deutsche Bank's portfolio in Q4 2017, its #5351 holding.
  • Deutsche Bank first reported a position in Rosetta Genomics in Q3 2017 and has held it in 2 quarters since.
  • 10 funds tracked by Wall St. Rank held Rosetta Genomics as of Q4 2017.

Based on Deutsche Bank's 13F filing for Q4 2017, filed 14 Feb 2018.